PHIO
Phio Pharmaceuticals Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.17
-0.08 ▼ -6.40%
🌙 3월 13일 7:58 PM ET (한국 3/14 08:58)
$1.17
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.5 | Insider Own | 11.57% | Shs Outstand | 0.01B | Perf Week | 0.86% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | 34.74% | Insider Trans | 1.51% | Shs Float | 0.01B | Perf Month | -9.3% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -0.23 | Inst Own | 3.13% | Short Float | 5.14% | Perf Quarter | - |
| Income | -0.01B | P/S | - | EPS this Y | 34.48% | Inst Trans | 3.27% | Short Ratio | 0.14 | Perf Half Y | -49.57% |
| Sales | 0.00B | P/B | 0.67 | EPS next 5Y | - | ROA | -63.9% | Short Interest | 0.53M | Perf YTD | 11.43% |
| Book/sh | 1.73 | P/C | 0.65 | EPS past 3/5Y | 74.81% 62.91% | ROE | -69.95% | 52W High | -72.08% ($4.19) | Perf Year | -12.03% |
| Cash/sh | 1.81 | P/FCF | - | Sales past 3/5Y | - | ROIC | -43.17% | 52W Low | 43.96% ($0.81) | Perf 3Y | -97.75% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 85.44% | Gross Margin | - | Volatility(W/M) | 7.32% 12.31% | Perf 5Y | -99.66% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.12 | Perf 10Y | -100% |
| Dividend Ex-Date | - | Quick Ratio | 16.03 | EPS Q/Q | 78.24% | Profit Margin | - | RSI (14) | 51.37 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 16.03 | Sales Q/Q | - | SMA20 | -0.17% ($1.17) | Beta | 0.84 | Target Price | $14 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 4.79% ($1.12) | Rel Volume | 0.09 | Prev Close | $1.25 |
| Employees | 6 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 55.88% - | SMA200 | -34.25% ($1.78) | Avg Volume(3M) | 3.90M | Price | $1.17 |
| IPO | 2012/5/10 | Option/Short | No/No | Trades | 649 | Volume | 368,266 | Change | -6.4% |
뉴스 로딩 중...